- Pseudomembranous colitis is due infection by Clostridium difficle
- A gram-positive anaerobic bacillus
- Not identified until 1953 because it was 'difficult' to culture
- Spores are commonly found in the hospital environment
Pathophysiology
- Normal stool contains >500 different bacteria at a concentration of
1012 per gram
- Antibiotic therapy can change the faecal flora
- Broad-spectrum antibiotics are main culprits
- Particular problem with lincomycin and clindomycin - but rarely used
- Allows colonisation by C. difficle transmitted by the
faecal-oral route
- Exotoxins (Toxin A & B) produced by bacteria are cytotoxic
- Act via cell membrane receptors
- Produces mucosal inflammation and cell damage
- If severe epithelial necrosis a pseudo-membrane is formed
- Consists of mucin, fibrin, leucocytes and cellular debris

Clinical features
- 50% of neonates are transient healthy carriers of C. difficle
- Only 1% of adults are also asymptomatic carriers
- 10% patients on antibiotics develop diarrhoea
- Only 1% develop pseudomembranous colitis
- The spectrum of symptomatic disease includes:
- Mild diarrhoea
- Colitis without pseudo-membrane formation
- Pseudomembranous colitis
- Fulminant colitis
- Diagnosis is confirmed by the detection of toxin in the stool by
ELISA
Treatment
Bibliography
Bartlett J G. Clinical practice: antibiotic-associated
diarrhoea. N Eng J Med 2002; 346: 334-339.
Cleary R K. Clostridium
difficle-associated diarrhea and colitis.
Dis Colon Rectum 1998;
41: 1435-1449.
Hurley B W, Nguyen C C. The spectrum of pseudomembranous
enterocolitis and antibiotic-associated diarrhoea. Arch Int Med
2002; 162: 2117-2184
Kelly C P, Pothoulakis C,
Lamont J T.
Clostridium difficle colitis.
N Eng J Med 1994; 330: 257-262.
Kyne L, Farrell R J, Kelly C P. Clostridium difficle.
Gastroenterol Clin North Am 2001; 30: 753-777.
Tonna I, Welsby P D. Pathogenesis and treatment of
Clostridium difficle infection. Postgrad Med J 2005;
81: 367-369. |